717. Potyrailo R.A., Conrad R.C., Ellington A.D., Hieftje G.M. Adapting selected nucleic acid ligands (aptamers) to biosensors // Anal. Chem. 1998. V.70. P.3419– 3425.
718.Proske D., Blank M., Buhmann R., Resch A. Aptamers: Basic research, drug development, and clinical applications // Appl. Microbiol. Biotechnol. 2005. V.69. P.367–374.
719.Proske D., Gilch S., Wopfner F., Schatzl H.M., Winnacker E.L., Famulok M. Prion-protein-specific aptamer reduces PrPSc formation // Chembiochemistry. 2002. V.3. P.717–725
720.Prudent J.R., Uno T., Schultz P.G. Expanding the scope of RNA catalysis // Science. 1994. V.264. P.1924-1927.
721.Puglisi J.D., Chen L., Blanchard S., Frankel A.D. // Science. 1995. V.270. P.1200.
722.Puglisi J.D., Chen L., Frankel A.D., Williamson J.R. // Proc. Natl. Acad. Sci. USA. 1993. V.90. P.3680.
723.Puglisi J.D., Williamson J.R. // R. F. Gesteland, T. R. Cech, J. F. Atkins, Eds. The RNA World. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2nd ed., 1999. P.403-425.
724.Purschke W.G., Eulberg D., Buchner K., Vonhoff S., Klussmann S. An L-RNA- based aquaretic agent that inhibits vasopressin in vivo // PNAS. 2006. V.103. P.51735178.
725.Purschke W.G., Radtke F., Kleinjung F., Klussmann S. A DNA Spiegelmer to staphylococcal enterotoxin B // Nucleic Acids Res. 2003. V.31. P.3027-3032.
726.Purtha W.E., Coppins R.L., Smalley M.K., Silverman S.K. General Deoxyribozyme-Catalyzed Synthesis of Native 3‘–5‘ RNA Linkages // J. Am. Chem. Soc. 2005. V.127. P.13124-13125.
727.Rathbone D.A., Bruce N.C. Microbial transformation of alkaloids // Curr. Opin. Microbiol. 2002. V.5. P.274–281.
728.Ravelet C., Grosset C., Peyrin E. Liquid chromatography, electrochromatography and capillary electrophoresis applications of DNA and RNA aptamers // J. Chromatogr. A. 2006. V.1117. P.1-10.
136
729.Reader J.S., Joyce G.F. A ribozyme composed of only two different nucleotides // Nature. 2002. V.420. P.841-844.
730.Reiter N.J., Maher III L.J., Butcher S.E. DNA mimicry by a high-affinity anti-NF- {kappa}B RNA aptamer // Nucleic Acids Res. 2008. V.36. P.1227-1236.
731.Rentmeister A., Bill A., Wahle T., Walter J., Famulok M. RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of {beta}- secretase BACE1 in vitro // RNA. 2006. V.12. P.1650-1660.
732.Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., Khvorova A. Rational siRNA design for RNA interference // Nat. Biotechnol. 2004. V.22. P.326–
330.
733.Rhie A., Kirby L., Sayer N., Wellesley R., Disterer P., Sylvester I., Gill A., Hope J., James W., Tahiri-Alaoui A. Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion // J. Biol. Chem. 2003. V.278. P.39697-39705.
734.Richards B., Karpilow J., Dunn C., Peterson I., Maxfield A., Zharkikh L., Abedi M., Hurlburt A., Hardman J., Hsu F., et al. Genetic Selection for Modulators of a Retinoic-Acid-Responsive Reporter in Human Cells // Genetics. 2003. V.163. P.10471060.
735.Rimmele M. Nucleic acid aptamers as tools and drugs: recent developments // Chembiochem. 2003. V.4. P.963–971.
736.Rink S.M., Shen J.C., Loeb L.A. Creation of RNA molecules that recognize the oxidative lesion 7,8-dihydro-8-hydroxy-2'-deoxyguanosine (8-oxodG) in DNA // Proc. Natl. Acad. Sci. USA. 1998. V.95. P.11619-11624.
737.Robertson M.P., Ellington A.D. In vitro selection of an allosteric ribozyme that transduces analytes to amplicons // Nat. Biotechnol. 1999. V.17. P.62–66.
738.Robertson M.P., Ellington A.D. Design and optimization of effector-activated ribozyme ligases // Nucleic Acids Res. 2000. V.28. P.1751–1759.
739.Robertson M.P., Ellington A.D. In vitro selection of nucleoprotein enzymes // Nat. Biotechnol. 2001. V.19. P.650–655.
740.Rogers J., Chang A.H., von Ahsen U., Schroeder R., Davies J. // J. Mol. Biol. 1996. V.259. P.916.
137
741.Rogers J., Joyce G.F. A ribozyme that lacks cytidine // Nature. 1999. V.402. P.323-325.
742.Rogers J., Joyce G.F. The effect of cytidine on the structure and function of an RNA ligase ribozyme // RNA. 2001. V.7. P.395-404.
743.Romero-Lopez C., Barroso-delJesus A., Puerta-Fernandez E., Berzal-Herranz A. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method // Biol. Chem. 2005. V.386. P.183-190.
744.Rosenstein S.P., Been M.D. Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions // Biochemistry. 1990. V.29. P.8011–8016.
745.Roth A., Breaker R.R. An amino acid as a cofactor for a catalytic polynucleotide // Proc. Natl. Acad. Sci. USA. 1998. V.95. P.6027-6031.
746.Rowsell S., Stonehouse N.J., Convery M.A., Adams C.J., Ellington A.D., Hirao I., Peabody D.S., Stockley P.G., Phillips S.E.V. Crystal structures of a series of RNA aptamers complexed to the same protein target // Nature Struct. Biol. 1998. V.5. P.970-975.
747.Roychowdhury-Saha M., Lato S.M., Shank E.D., Burke D.H. Flavin recognition by an RNA aptamer targeted toward FAD // Biochemistry. 2002. V.41. P.2492-2499.
748.Ruckman J., Green L.S., Beeson J., Waugh S., Gillette W.L., Henninger D.D., Claesson-Welsh L., Janjic N. 2'-Fluoroprymidine RNA-based aptamers to the 165amino acid form of vascular endothelial growth factor (VEGF165) // J. Biol. Chem. 1998. V.273. P.20556–20567.
749.Rusconi C.P., Roberts J.D., Pitoc G.A., Nimjee S.M., White R.R., Quick G. Jr., Scardino E., Fay W.P., Sullenger B.A. Antidote-mediated control of an anticoagulant aptamer in vivo // Nat. Biotechnol. 2004. V.22. P.1423-1428.
750.Rusconi C.P., Scardino E., Layzer J., Pitoc G.A., Ortel T.L., Monroe D., Sullenger B.A. RNA aptamers as reversible antagonists of coagulation factor IXa // Nature. 2002. V.419. P.90–94.
751.Rusconi C.P., Yeh A., Lyerly H.K., Lawson J.H., Sullenger B.A. Blocking the initiation of coagulation by RNA aptamers to factor VIIa // Thromb. Haemost. 2000. V.84. P.841-848.
138
752.Russell R., Zhuang X., Babcock H.P., Millett I.S., Doniach S., Chu S., Herschlag D. Exploring the folding landscape of a structured RNA // Proc. Natl Acad. Sci. USA. 2002. V.99. P.155–160.
753.Sabeti P.C., Unrau P.J., Bartel D.P. Accessing rare activities from random RNA sequences: the importance of the length of molecules in the starting pool // Chem. Biol. 1997. V.4. P.767–774.
754.Saha S., Ansari A.Z., Jarrell K.A., Ptashne M. RNA sequences that work as transcriptional activating regions // Nucleic Acids Res. 2003. V.31. P.1565-1570.
755.Saito H., Kourouklis D., Suga H. An in vitro evolved precursor tRNA with aminoacylation activity // EMBO J. 2001. V.20. P.1797-1806.
756.Saito H., Suga H. Outersphere and innersphere coordinated metal ions in an aminoacyl-tRNA synthetase ribozyme // Nucleic Acids Res. 2002. V.30. P.5151-5159.
757.Sakamoto T., Oguro A., Kawai G., Ohtsu T., Nakamura Y. NMR structures of double loops of an RNA aptamer against mammalian initiation factor 4A // Nucleic Acids Res. 2005. V.33. P.745-754.
758.Salehi-Ashtiani K., Szostak J.W. In vitro evolution suggests multiple origins for the hammerhead ribozyme // Nature. 2001. V.414. P.82–84.
759.Sandy P., Ventura A., Jacks T. Mammalian RNAi: A practical guide // Biotechniques. 2005. V.39. P.215–224.
760.Santoro S.W., Joyce G.F. A general purpose RNA-cleaving DNA enzyme // Proc. Natl. Acad. Sci. USA. 1997. V.94. P.4262–4266.
761.Santoro S.W., Joyce G.F., Sakthivel K., Gramatikova S., Barbas C.F. III. RNA cleavage by a DNA enzyme with extended chemical functionality // J. Am. Chem. Soc. 2000. V.122. P.2433-2439.
762.Santulli-Marotto S., Nair S.K., Rusconi C., Sullenger B., Gilboa E. Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity // Cancer Res. 2003. V.63. P.7483-7489.
763.Saran D., Frank J., Burke D.H. The tyranny of adenosine recognition among RNA aptamers to coenzyme A // BMC Evol. Biol. 2003. V.3. P.26.
764.Sassanfar M., Szostak J.W. An RNA motif that binds ATP // Nature. 1993. V.364. P.550–553.
139
765.Sayer N.M., Cubin M., Rhie A., Bullock M., Tahiri-Alaoui A., James W. Structural determinants of conformationally selective, prion-binding aptamers // J. Biol. Chem. 2004. V.279. P.13102-13109.
766.Sazani P.L., Larralde R., Szostak J.W. A small aptamer with strong and specific recognition of the triphosphate of ATP // J. Am. Chem. Soc. 2004. V.126. P.83708371.
767.Scarabino D., Crisari A., Lorenzini S., Williams K., Tocchini-Valentini G.P. tRNA prefers to kiss // EMBO J. 1999. V.18. P.4571-4578.
768.Scaringe S.A., Wincott F.E., Caruthers M.H. Novel RNA synthesis method using 5'-O-silyl-2'-O-orthoester protecting groups // J. Am. Chem. Soc. 1998. V.120. P.11820–11821.
769.Schlatterer J.C., Stuhlmann F., Jäschke A. Stereoselective synthesis using
immobilized Diels-Alderase ribozymes // Chembiochem. 2003. V.4. P.1089–1092.
770.Schlosser K., Lam J.C.F., Li Y. Characterization of long RNA-cleaving deoxyribozymes with short catalytic cores: the effect of excess sequence elements on the outcome of in vitro selection // Nucleic Acids Res. 2006. V.34. P.2445-2454.
771.Schmidt K.S., Borkowski S., Kurreck J., Stephens A.W., Bald R., Hecht M., Friebe M., Dinkelborg L., Erdmann V.A. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function // Nucleic Acids Research. 2004. V.32. P.5757-5765.
772.Schneider D., Tuerk C., Gold L. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein // J. Mol. Biol. 1992. V.228. P.862-869.
773.Schubert S., Gul D.C., Grunert H.P., Zeichhardt H., Erdmann V.A., Kurreck J.
RNA leaving ‗10–23‘ DNAzymes with enhanced stability and activity // Nucleic
Acids Res. 2003. V.31. P.5982–5992.
774.Schultes E.A., Bartel D.P. One sequence, two ribozymes: implications for the emergence of new ribozyme folds // Science. 2000. V.289. P.448-452.
775.Schultes E.A., Spasic A., Mohanty U., Bartel D.P. Compact and ordered collapse of randomly generated RNA sequences // Nat. Struct. Mol. Biol. 2005. V.12. P.1130–
1136.
140